These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8048212)

  • 1. Is colchicine effective in Peyronie's disease? A pilot study.
    Akkus E; Carrier S; Rehman J; Breza J; Kadioglu A; Lue TF
    Urology; 1994 Aug; 44(2):291-5. PubMed ID: 8048212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study.
    Safarinejad MR
    Int J Impot Res; 2004 Jun; 16(3):238-43. PubMed ID: 14973528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
    Paulis G; Brancato T
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome.
    Kadioglu A; Tefekli A; Köksal T; Usta M; Erol H
    Int J Impot Res; 2000 Jun; 12(3):169-75. PubMed ID: 11045911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease.
    Prieto Castro RM; Leva Vallejo ME; Regueiro Lopez JC; Anglada Curado FJ; Alvarez Kindelan J; Requena Tapia MJ
    BJU Int; 2003 Apr; 91(6):522-4. PubMed ID: 12656907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long term sildenafil on the acute phase of Peyronie's disease in a combination treatment.
    Topcuoglu M; Çakan M
    Arch Ital Urol Androl; 2022 Sep; 94(3):319-322. PubMed ID: 36165478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
    Ralph DJ; Abdel Raheem A; Liu G
    J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
    Jordan GH
    J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin deposition in Peyronie's disease plaque.
    Somers KD; Dawson DM
    J Urol; 1997 Jan; 157(1):311-5. PubMed ID: 8976287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between penile fracture and Peyronie's disease: a prospective study.
    Acikgoz A; Gokce E; Asci R; Buyukalpelli R; Yilmaz AF; Sarikaya S
    Int J Impot Res; 2011; 23(4):165-72. PubMed ID: 21654815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cellular effects of colchicine in fibromatosis.
    Dominguez-Malagon HR; Alfeiran-Ruiz A; Chavarria-Xicotencatl P; Duran-Hernandez MS
    Cancer; 1992 May; 69(10):2478-83. PubMed ID: 1568169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.